Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis. Austria, Bisphosphonate, Finite Elements Analysis, GE-Lunar, Ibandronate, Longitudinal, Sclerostin, Treatment (anti-osteoporotic treatments)
Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Alendronate, Bisphosphonate, Calcium, Denosumab, GE-Lunar, Longitudinal, Risedronate, Spain, Teriparatide, Testosterone, Treatment (anti-osteoporotic treatments), Vitamin D
Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer Aromatase inhibitor, Breast cancer, Cancer, Exemestane, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Tamoxifen, Treatment (anti-osteoporotic treatments)
Insights on accelerated skeletal repair in Cushing’s disease Case report, Cushing Syndrome, Endocrinology, GE-Lunar, Glucocorticoids, Longitudinal, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), USA
Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial. GE-Lunar, Longitudinal, Treatment (anti-osteoporotic treatments), USA, Vitamin D
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a Bisphosphonate, Hologic, Ibandronate, Longitudinal, Osteoporosis, Switzerland, Teriparatide, Treatment (anti-osteoporotic treatments)
Longitudinal changes of trabecular bone score after estrogen deprivation: effect of menopause and aromatase inhibition. Aromatase inhibitor, Estrogen, Hologic, Italy, Longitudinal, Secondary osteoporosis
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women Antiresorptive therapy, Bisphosphonate, Calcitonin, Canada, GE-Lunar, Longitudinal, Raloxifene, Treatment (anti-osteoporotic treatments)
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study Bisphosphonate, Hologic, Longitudinal, Osteoporosis, Switzerland, Treatment (anti-osteoporotic treatments), Zoledronate
Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment. Bulgaria, Denosumab, GE-Lunar, Glucocorticoids, Longitudinal, Osteoporosis, Secondary osteoporosis, Treatment (anti-osteoporotic treatments)